WEBULL
News
VACH
10.64
0.00%
0.00
Xlife Sciences AG Advances VERAXA Biotech NASDAQ Listing After SEC Filing Update
Reuters · 11/28/2025 12:13
Voyager Acquisition Corp. Extends Veraxa Deal Deadline and Removes Termination Fee
Reuters · 10/21/2025 10:04
VERAXA Biotech And Secarna Pharmaceuticals Enters Strategic Research Collaboration To Develop Next-Generation Antibody Oligonucleotide Conjugates
Benzinga · 09/30/2025 12:05
Weekly Report: what happened at VACH last week (0908-0912)?
Weekly Report · 09/15/2025 12:23
Weekly Report: what happened at VACH last week (0901-0905)?
Weekly Report · 09/08/2025 12:25
Weekly Report: what happened at VACH last week (0825-0829)?
Weekly Report · 09/01/2025 12:18
Weekly Report: what happened at VACH last week (0818-0822)?
Weekly Report · 08/25/2025 12:35
Weekly Report: what happened at VACH last week (0811-0815)?
Weekly Report · 08/18/2025 12:22
Weekly Report: what happened at VACH last week (0804-0808)?
Weekly Report · 08/11/2025 12:34
Weekly Report: what happened at VACH last week (0728-0801)?
Weekly Report · 08/04/2025 12:38
Weekly Report: what happened at VACH last week (0721-0725)?
Weekly Report · 07/28/2025 12:38
Weekly Report: what happened at VACH last week (0714-0718)?
Weekly Report · 07/21/2025 12:24
Voyager Acquisition, VERAXA announce filing of Form F-4 registration statement
TipRanks · 07/17/2025 13:16
Voyager Acquisition Corp. and VERAXA Biotech Announce Filing of Form F-4 for Business Combination, Targeting Q4 2025 Completion
Reuters · 07/17/2025 12:55
VERAXA BIOTECH AND VOYAGER ACQUISITION CORP. ANNOUNCE FILING OF FORM F-4 REGISTRATION STATEMENT WITH THE SEC
Reuters · 07/17/2025 12:55
Press Release: VERAXA Biotech and Voyager Acquisition Corp. Announce Filing of Form F-4 Registration Statement with the SEC
Dow Jones · 07/17/2025 12:55
Press Release: VERAXA Biotech and Voyager -2-
Dow Jones · 07/17/2025 12:55
VERAXA Biotech AG, a Subsidiary of Xlife Sciences AG, Reaches Key Milestone with F-4 Filing for NASDAQ Listing
Reuters · 07/17/2025 05:01
Xlife Sciences AG Announces Key Milestone as VERAXA Biotech Files Form F-4 for NASDAQ Listing
Reuters · 07/17/2025 05:01
VOYAGER ACQUISITION CORP - ENTERS JOINDER AGREEMENT WITH VERAXA BIOTECH - SEC FILING
Reuters · 07/16/2025 21:31
More
Webull provides a variety of real-time VACH stock news. You can receive the latest news about Voyager Acquisition Corp through multiple platforms. This information may help you make smarter investment decisions.
About VACH
Voyager Acquisition Corp. is a blank check company. The Company is formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company has not selected any business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. It may pursue an initial business combination in any business or industry. The Company has not conducted any operations and has generated no revenues.